Figure 1From: Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective studySchematic of the study protocol. The 141 patients treated with prophylaxis trimethoprim/sulfamethoxazole (TMP/ SMX (+)) were excluded from the analysis, and the 561 patients who did not receive prophylaxis (TMP/ SMX (-)) were analyzed to reveal risk factors for Pneumocystis pneumonia (PCP).Back to article page